Site: |
University of Miami, Sylvester Comprehensive Cancer Center |
|||
Address: |
1475 Northwest 12th Ave |
|||
City: |
Miami |
|||
State: |
FL |
|||
Zip: |
33136 |
|||
Country: |
USA |
1 |
Ongoing, but not recruiting |
Closed |
ARQ 092 |
NCT01473095 |
|
3 |
Active, not recruiting |
Active |
Avapritinib or Regorafenib |
NCT03465722 |
|
2 |
Active, not recruiting |
Closed |
Axitinib + Pembrolizumab |
NCT02636725 |
|
3 |
Recruiting |
Active |
Bezuclastinib plus Sunitinib |
NCT05208047 |
|
2 |
Recruiting |
Not yet activated |
Bezuclastinib plus Sunitinib |
NCT06208748 |
|
1 |
Active, not recruiting |
Closed |
BLU-285 |
NCT02508532 |
|
2 |
Active, not recruiting |
Closed |
CB-839 |
NCT03872427 |
|
3 |
Active, not recruiting |
Closed |
Crenolanib (CP-868,596) |
NCT02847429 |
|
2 |
Recruiting |
Active |
ctDNA plus Sunitinib or Regorafenib |
NCT05366816 |
|
1/2 |
Recruiting |
Active |
DCC-3116 + Ripretinib |
NCT05957367 |
|
1 |
Suspended |
Closed |
Dendritic Cell Vaccine |
NCT01803152 |
|
1 |
Recruiting |
Active |
IDRX-42 |
NCT05489237 |
|
1 |
Completed |
Closed |
Imatinib + BYL719 |
NCT01735968 |
|
3 |
Unknown |
Active |
Masitinib or Sunitinib |
NCT01694277 |
|
3 |
Terminated |
Active |
Masitinib, (AB1010) |
NCT00812240 |
|
2 |
Completed |
Closed |
Nivolumab + Ipilimumab |
NCT02500797 |
|
1 |
Completed |
Closed |
PLX9486 + PLX3397 |
NCT02401815 |
|
1 |
Active, not recruiting |
Closed |
PT2977 |
NCT02974738 |
|
1 |
Active, not recruiting |
Closed |
QINLOCK
Ripretinib
DCC-2618 |
NCT02571036 |
|
3 |
Active, not recruiting |
Active |
QINLOCK
Ripretinib
DCC-2618
SUTENT
Sunitinib |
NCT03673501 |